<DOC>
	<DOCNO>NCT00020007</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Heating paclitaxel several degree body temperature infusing affect area around tumor may kill tumor cell . PURPOSE : This phase I trial study side effect best dose paclitaxel give hyperthermic perfusion treat patient lung cancer lung metastases remove surgery .</brief_summary>
	<brief_title>Paclitaxel Hyperthermic Perfusion Treating Patients With Lung Cancer Lung Metastases That Can Be Removed By Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose phase II dose paclitaxel administer via hyperthermic retrograde isolate lung perfusion patient unresectable pulmonary malignancy . - Determine nature toxic effect regimen patient population . - Evaluate pharmacokinetic profile regimen patient . - Determine relationship pharmacodynamic parameter toxic effect regimen patient . OUTLINE : This dose-escalation study paclitaxel . Patients undergo posterolateral thoracotomy median sternotomy . Patients receive paclitaxel 90 minute administer via hyperthermic retrograde isolate lung perfusion . The entire surgery last approximately 4 hour . Cohorts 3-6 patient receive escalate dos paclitaxel maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose-limiting toxicity . Patients follow 1 2 month . Patients respond disease continue follow every 3 month . PROJECTED ACCRUAL : A maximum 31 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm unresectable primary lung cancer pulmonary metastasis unresectable basis technical consideration sufficiently numerous recurrent , potentially inoperable disease highly probable Bilateral metastasis allow Unresectable bronchoalveolar carcinoma allow Previously treat primary lung cancer allow Disease outside confines thorax allow , provide bulk disease chest clearly great threat survival and/or extrathoracic disease control No potentially treatable pulmonary metastasis lymphomas germ cell tumors No biopsy proven interstitial fibrosis , radiation induce pneumonitis , evidence significant pulmonary hypertension history , radiologic , echocardiographic , catheterization study No active intracranial leptomeningeal metastasis Prior resection radiotherapy intracranial metastasis allow follow criterion meet : No active disease 2 MRIs do one month apart No requirement anticonvulsant medication steroid Adequate pulmonary reserve tolerate pneumonectomy : Oxygen consumption great 50 % predict AND FEV1 DLCO great 80 % predict OR FEV1 DLCO le 80 % predict allow postoperative FEV1 DLCO least 40 % predicted basis split function V/Q scan Prior radiotherapy chest allow provided 6 month elapse since completion treatment history , current evidence , interstitial lung disease PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : More 3 month Hematopoietic : Platelet count great 100,000/mm^3 Hemoglobin great 10 g/dL WBC great 3,500/mm^3 Hepatic : PT/PTT normal Bilirubin le 1.5 time upper limit normal ( ULN ) AST/ALT le 1.5 time ULN Renal : Creatinine le 1.6 mg/dL Cardiovascular : Fixed defect thallium scan ejection fraction great 40 % allow Reversible ischemic defect allow cardiology clearance Pulmonary : See Disease Characteristics Resting oxygen saturation great 90 % pCO_2 le 45 mmHg arterial blood gas Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No active infection HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : More 30 day since prior biologic therapy malignancy Chemotherapy : More 30 day since prior chemotherapy malignancy Prior paclitaxel allow No prior bleomycin , nitrosoureas , busulfan Endocrine therapy : See Disease Characteristics Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics Prior thoracic surgery allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>lung metastasis</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
</DOC>